{"id":"W2801354368","doi":"10.1111/bjh.15232","title":"A tale of two antibodies: obinutuzumab <i>versus</i> rituximab","year":2018,"lang":"en","type":"review","venue":"British Journal of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"Centers for Disease Control and Prevention","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Clinical trial; Immunology; Oncology; Context (archaeology); Dosing; Lymphoma; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001137951,0.0004173053,0.006536482,0.0006350225,0.00007962186,0.00004464854,0.0006663426,0.0005341556,0.003470026],"category_scores_gemma":[0.0007040258,0.0004026787,0.001762258,0.000479672,0.0008906525,0.0001164896,0.0001978368,0.001498854,0.0001264411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003839437,"about_ca_system_score_gemma":0.002595046,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000125671,"about_ca_topic_score_gemma":0.00007163855,"domain_scores_codex":[0.995425,0.0005419766,0.002226747,0.0003887295,0.0007939721,0.0006235484],"domain_scores_gemma":[0.9956473,0.0006492973,0.001845672,0.0005252052,0.001020796,0.0003117181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007113132,0.0005348206,0.000007220005,0.03033866,0.002471676,0.08166056,0.00007998366,9.19287e-8,0.00002823397,0.0001052956,0.04259359,0.8414686],"study_design_scores_gemma":[0.004850871,0.0008275688,5.202619e-7,0.02596785,0.001119925,0.3917153,0.00002956196,9.228502e-7,0.00003292225,0.00005520598,0.5752349,0.0001644432],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001722433,0.9919973,0.00003398582,0.00004157463,0.001233658,0.0006567418,0.00007848397,0.00001770279,0.004218129],"genre_scores_gemma":[0.00009794803,0.9963118,0.001061846,0.00004711071,0.0008397003,0.0000115871,0.00003766678,0.0001135096,0.001478845],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8413041,"threshold_uncertainty_score":0.9998425,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06548623625567729,"score_gpt":0.3994626126605701,"score_spread":0.3339763764048929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}